Noxxon adds to venture backers with €33M round

In an unusually large round for a European biotech, Berlin's Noxxon Pharma raised €33 million ($40 million) in a Series D that attracted a long lineup of European venture funds. New investor NGN Capital spearheaded the round, leading a pack that included existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG...